Navigation Links
Study IDs Protein That Inhibits HIV From Growing In Cell Cultures

ly destroys. HIV attaches to this T-cell by first landing on a receptor called CD4. Once it reacts with the receptor, HIV can enter the cell, multiply and destroy the T-cell, thereby causing immune deficiency.

"People with GBV-C have a slower rate of destruction of these T-cells," said Stapleton, who also is director of the Division of Infectious Diseases at the Iowa City VA and UI.

The current study shows that the newly identified protein, NS5A, inhibits HIV in part by decreasing the number of CD4 receptors available to HIV. With fewer places for HIV to "dock," less HIV enters the cells to inflict destruction.

However, Xiang cautioned, this is only part of the story, and the researchers must continue work to understand how the NS5A protein exerts its total effect.

"Before NS5A can be used for any kind of therapy, we need to further map it," Xiang said. "We need to zero in to see what region has the critical effect on HIV inhibition."

Once that is accomplished, the team will seek to develop small molecular drugs that mimic the inhibiting action.

Stapleton noted that GBV-C is not toxic to T-cells and is not associated with any human disease. As a result, the U.S. Food and Drug Administration does not require that blood donations be screened for this common virus.

Up to 3 percent of healthy blood donors in the United States have active GBV-C infection. An additional 12 percent have antibodies indicating past exposure at the time of donation. Because the GBV-virus is transmitted through bodily fluids, as is HIV, many HIV-positive individuals have evidence of past or present infection with GBV-C.

Stapleton and Xiang first began studying the GBV-C and HIV connection because they were skeptical of earlier studies published in the mid-1990s.

"It was a strange story," Stapleton said. "Who would have thought a virus floating around in a lot of people does not make them
'"/>




Page: 1 2 3

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
(Date:7/25/2008)...hip Based on Significant Improvements in Members, ...r, Inc., a leader in health,care quality managemen...announced it has entered into a long-term agreemen...ark,s Collaboration on Quality(SM) Incent and,Rewa...een Wellmark and,primary care clinicians to promot...
(Date:7/25/2008)...., July 25 /PRNewswire/ -- Sagent Pharmaceuticals,...ompany, today announced that it,has launched amiod...ic,indicated for the treatment and prophylaxis of ...hemodynamically unstable ventricular,tachycardia -...eat.,Sagent,s amiodarone HCl injection will be ava...
(Date:7/25/2008)...t ALS Therapy Alliance to be presented at Fenway P...OCKET, R.I., July 25 /PRNewswire/ -- CVS/pharmacy ...ord-breaking $4.4 million in just 21 days,through ...esearch. This is,the seventh year of the annual fu...han $15 million for ALS research. This year,s fund...
(Date:7/25/2008)...ack-up in esophagus can cause immune system change...- The first evidence linking gastroesophageal refl...y Duke University Medical Center researchers. ,...st noted in the 1970s, and since then studies have...sthma patients also experience GERD symptoms. But ...
Breaking Medicine News(10 mins):Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2
...s in Singapore are on the rise and data show that ...ch 954 are dead, 631 are confirmed to have AIDS an... and the Singapore senior minister of health Balaj...e to inform the public that wives of HIV positive ...
...nment which intends to stabilize the rates of HIV ...worth atleast 4.1 US dollars to HIV infected indiv...ned to reduce the rate of HIV infection to below 0...ted population of Vietnam approximates to nearly 8...
...zardous activity is a well-known fact. Now two res...te ban on smoking in that country since it affects...eatments for the same//. University of Otago's As...ck Wilson say that the New Zealand governments nee...
...ed by Austrian researchers at the annual meeting o...cago on Friday say that caffeine has the ability t...e areas in the brain that control this activity. ... quantities in coffee, tea, soft drinks and chocol...
Other Medicine News:
(Date:7/24/2008)...ORK, July 24 /- MacroChem C...ced results of a Phase 2 clinical trial,involving ...nter,open-label efficacy and safety study of EcoN...t of onychomycosis (nail fungus). The composite,pr... cure" defined as,negative mycology (negative fung...
(Date:7/23/2008)... results pending publication in July print edition...able on Web, INDIANAPOLIS, July 23 /...ting the use of N-terminal pro-B-type natriuretic ...f NT-proBNP for risk,stratification in predicting ...in patients treated with non-steroidal anti-inflam...
(Date:7/23/2008)...N, July 23 /- FluoroPharma Inc., a co...ents for the Positron Emission Tomography,(PET) ma..., its novel,Fluorine-18 labeled tracer for myocard...ond cardiovascular product to complete Phase I cli... designed to assess the blood flow in the,heart (m...
(Date:7/23/2008)...LE, July 23 /- Dendreon Cor...expects the Independent Data,Monitoring Committee ...sis,of overall survival relating to the Company,s ...rcinoma Treatment, also known as D9902B) clinical ...he Company,s investigational,active cellular immun...
Breaking Medicine Technology:MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Infection outbreaks on teeth can cause alopecia areata or localized hair loss 6950 1Infection outbreaks on teeth can cause alopecia areata or localized hair loss 6950 2Canceled 3A Homecare Rally in Contra Costa County 6949 1Study Shows Cholera Can be Controlled With Oral Vaccines 6947 1Study Shows Cholera Can be Controlled With Oral Vaccines 6947 2Study Shows Cholera Can be Controlled With Oral Vaccines 6947 3Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 1Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 2Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 3
...7 - Researchers at,the Stanford University School ...their new study indicating that an antidepressant,...avioral disorder,known as compulsive buying, did n...who took it., The medication is escitalopram, a co...and name Lexapro. In the study,researchers found ...
...roduct in,AM-Pharma,s pipeline , BUNNIK, The Nethe...rmaceutical company developing novel therapeutics ...ay announced positive,results in patients with Acu...group of a Phase IIa trial with Alkaline Phosphata... a marker for renal function,improved by 45% (med...
Other Medicine Technology:Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 2AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 3
...t reading of entire racks. Its scanner-based image...s in approximately 10 seconds per rack. Decoded tu...of ActiveX controls is provided to allow for integ...HP Scanner and software. Compatible with Windows 2...
Sealed laminate workbench top with powder-coated steel legs. Height is adjustable from 25"-34". Available in hundreds of sizes and configurations. Accessories include shelves, drawers, light fixtures
Round, height-adjustable, steel laboratory stools with small footprint for small spaces • Choose options like different height-adjustment mechanism or paint finish. • your choice of color
...cal safety labs (BSL) and pharmaceutical applicati...nd easy sterilization. Panels are precision-joined...wipe down and disinfect. One-inch radius corners s...creates strong, rigid surface without external bra...
Medicine Products: